“We’re ready to get doses rolling... With Pfizer, Moderna and now AstraZeneca, Canada will get to more than 6.5 million doses by the end of March.”​. AstraZeneca’s COVID-19 vaccine and the ‘seniors’ question. Canada on Friday approved AstraZeneca's COVID-19 vaccine, including the version produced by the Serum Institute of India, and 500,000 doses are due to arrive next week. One of the reasons is because of a mix-up in how big the doses were during the clinical trials. “For someone 65 years and older, the question is, the benefits of getting the vaccine versus not, will it outweigh the risk? The approval by Health Canada follows that of Pfizer and Moderna, both of which also require two doses. A version of the AstraZeneca vaccine by the Indian pharmaceutical company Serum Institute of India and sponsored by Verity Pharmaceuticals Inc. in Canada has also been approved for use and is considered a separate vaccine by Health Canada. Preliminary findings from Oxford University, co-developer of the vaccine, hint that it may also reduce transmission of the virus and offers strong protection for three months on just a single dose. It was initially reported the drugmaker would not be able to fulfil its second-quarter supply commitment to the EU due to production issues. The two-dose vaccines have been approved for use in people 18 years of age and older, including seniors, with the recommendation that the second dose be administered between four and 12 weeks after the first, officials said Friday. OTTAWA— It appears Canada’s approval of AstraZeneca’s COVID-19 vaccine is close. The AstraZeneca shot has already been approved in more than 50 countries, including the United Kingdom, India, Australia and the European Union. reports 278 new COVID-19 cases, including six new variants, B.C. It may also be a strong contender in the protection against COVID-19 variants, particularly the B.1.1.7 variant. AstraZeneca approval may slow disapproval News of the approval of the AstraZeneca vaccine comes as a great relief to Canadians. As well, officials anticipate 1.9 million doses as part of the global vaccine-sharing program known as COVAX. Health Canada's approval of the Oxford-AstraZeneca vaccine has firmed up the government's stated goal of shots for everyone who wants them by the end of September. Some volunteers only received a half dose at first, according to Dr. Supriya Sharma, Health Canada’s chief medical adviser. Health Canada has been reviewing AstraZenecaand Oxford University’s vaccine since it was submitted for approval on Oct. 1 as more and more … This type of vaccine, which uses a modified cold virus commonly found in chimpanzees, has been in use for decades, said Health Canada's chief medical adviser, Dr. Supriya Sharma, on Friday. It means more people vaccinated and sooner,” said Prime Minister Justin Trudeau at a press conference on Friday. Your COVID-19 vaccine questions answered, One-way shopping aisles can help reduce direct COVID-19 transmission, study suggests, U.S. advisers endorse single-shot COVID-19 vaccine from J&J, Ontario records more than 1,200 new COVID-19 cases, marking fourth daily increase, Quebec reports 815 new COVID-19 cases, 400K vaccine doses administered, Numb to the numbers: Canadians desensitized to COVID-19 case and death rates, Queen says COVID-19 vaccine is quick, painless and helps others, Head of Canada's largest pension plan resigns after receiving COVID-19 vaccine in Dubai: memo, Pfizer COVID-19 vaccine reduces transmission after one dose: U.K. study. say it’s premature to come to any conclusions. Viral vector vaccines use a “harmless modified version of a different virus -- the vector -- to deliver instructions to our cells,” she said. Please read our Commenting Policy first. The vast majority of adverse reactions in trials were “mild to moderate” in severity, Sharma said, and were resolved “within a few days.”. Canada has approved the use of the AstraZeneca COVID-19 vaccine, allowing millions of doses to be added to the country’s beleaguered vaccine rollout. “A great match between a circulating flu strain and the vaccine in a given year might not exceed 60 per cent. Health Canada approved the AstraZeneca vaccine for use in people 18 and over, expressing confidence it would work for the elderly even though some … Health Canada’s chief medical adviser Dr. Supriya Sharma said … Canada is set to get the bulk of its vaccines from the U.S., but potentially factories in Europe, too. CTV News Infectious Disease Specialist Dr. Abdu Sharkawy said people concerned about the efficacy of the AstraZeneca vaccines should look to a regular flu season for some “perspective.”. Health Canada has approved the AstraZeneca COVID-19 vaccine. “Evidence suggests the efficacy increases with longer dosing intervals… that’s what was reflected in the clinical trials,” Sharma said. Canada has an agreement with AstraZeneca to buy 20 million doses of its vaccine, which is still awaiting approval from Health Canada. reports 1,462 COVID-19 cases, 11 deaths, WHO says coronavirus unlikely to have leaked from lab in China, 'No issues': Drinking alcohol won't affect COVID-19 vaccine efficacy, doctors say, 'It's garbage': Infectious disease expert debunks 'Facts Not Fear' COVID-19 flyer, Lonely or alone?